Title |
The Treatment Cascade for Chronic Hepatitis C Virus Infection in the United States: A Systematic Review and Meta-Analysis
|
---|---|
Published in |
PLOS ONE, July 2014
|
DOI | 10.1371/journal.pone.0101554 |
Pubmed ID | |
Authors |
Baligh R. Yehia, Asher J. Schranz, Craig A. Umscheid, Vincent Lo Re |
Abstract |
Identifying gaps in care for people with chronic hepatitis C virus (HCV) infection is important to clinicians, public health officials, and federal agencies. The objective of this study was to systematically review the literature to provide estimates of the proportion of chronic HCV-infected persons in the United States (U.S.) completing each step along a proposed HCV treatment cascade: (1) infected with chronic HCV; (2) diagnosed and aware of their infection; (3) with access to outpatient care; (4) HCV RNA confirmed; (5) liver fibrosis staged by biopsy; (6) prescribed HCV treatment; and (7) achieved sustained virologic response (SVR). |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 14% |
Argentina | 1 | 14% |
Switzerland | 1 | 14% |
Spain | 1 | 14% |
United States | 1 | 14% |
Unknown | 2 | 29% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | <1% |
United States | 1 | <1% |
Switzerland | 1 | <1% |
Unknown | 212 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 42 | 20% |
Student > Master | 32 | 15% |
Other | 27 | 13% |
Student > Ph. D. Student | 23 | 11% |
Student > Doctoral Student | 22 | 10% |
Other | 37 | 17% |
Unknown | 32 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 96 | 45% |
Nursing and Health Professions | 22 | 10% |
Agricultural and Biological Sciences | 16 | 7% |
Social Sciences | 11 | 5% |
Immunology and Microbiology | 6 | 3% |
Other | 25 | 12% |
Unknown | 39 | 18% |